Algorae Pharmaceuticals Limited
Research Algorae Pharmaceuticals Limited (LHI0) on Bullrun: market cap EUR 9.12M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLHI0
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 9.12M
- Financial periodFY2025
Valuation Snapshot
latest market cap is EUR 9.12M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a |
| FY2024 | n/a | -AUD 2.10M | -AUD 1.52M | n/a | 0 | AUD 3.11M | n/a | AUD 3.01M |
| FY2023 | n/a | -AUD 2.11M | -AUD 1.99M | n/a | 0 | AUD 6.13M | n/a | AUD 3.76M |
| FY2022 | n/a | -AUD 1.96M | -AUD 2.05M | n/a | 0 | AUD 7.24M | n/a | AUD 4.03M |
| FY2021 | n/a | -AUD 1.46M | -AUD 1.46M | n/a | n/a | AUD 1.57M | n/a | AUD 1.38M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 9.12M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Algorae Pharmaceuticals Limited
Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer's disease;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Algorae Pharmaceuticals Limited's market cap?
Algorae Pharmaceuticals Limited's market capitalization is EUR 9.12M.
What does Algorae Pharmaceuticals Limited do?
Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.